| 2025-09-22 |
13D/A |
XCUR / Exicure, Inc. |
HiTron Systems Inc. |
3,333,333 |
52.80 |
0.00 |
| 2025-09-19 |
13D/A |
PGEN / Precigen, Inc. |
Kirk Randal J |
146,295,359 |
39.40 |
25.21 |
| 2025-09-19 |
13D/A |
AWHL / Aspira Women's Health Inc. |
Schuler Jack W |
3,830,365 |
9.10 |
40.89 |
| 2025-09-19 |
13D/A |
BFRI / Biofrontera Inc. |
Deutsche Balaton Aktiengesellschaft |
2,552,230 |
19.99 |
456.18 |
| 2025-09-19 |
13D |
ARTL / Artelo Biosciences, Inc. |
Farb Daniel Stuart |
153,000 |
9.80 |
|
| 2025-09-19 |
13D/A |
HYPD / Hyperion DeFi, Inc. |
Avenue Venture Opportunities Fund, L.P. |
240,124 |
4.20 |
-32.22 |
| 2025-09-18 |
13D |
CGON / CG Oncology, Inc. |
Longitude Capital Partners IV, LLC |
4,662,268 |
6.00 |
-0.00 |
| 2025-09-18 |
13D |
CGON / CG Oncology, Inc. |
Seven Fleet Partners LP |
1,515,151 |
2.00 |
|
| 2025-09-18 |
13D/A |
LVTX / LAVA Therapeutics N.V. |
Versant Venture Capital VI, L.P. |
2,370,533 |
9.00 |
-30.42 |
| 2025-09-18 |
13D/A |
RDY / Dr. Reddy's Laboratories Limited - Depositary Receipt (Common Stock) |
G.V. Prasad |
113,356,510 |
13.58 |
|
| 2025-09-17 |
13D/A |
HYPD / Hyperion DeFi, Inc. |
Avenue Venture Opportunities Fund, L.P. |
354,291 |
6.20 |
-18.64 |
| 2025-09-15 |
13D/A |
DNTH / Dianthus Therapeutics, Inc. |
Fairmount Funds Management LLC |
4,052,052 |
9.90 |
37.01 |
| 2025-09-12 |
13D |
TLPH / Talphera, Inc. |
CorMedix Inc. |
9,090,909 |
19.95 |
|
| 2025-09-12 |
13D/A |
VOR / Vor Biopharma Inc. |
Reprogrammed Interchange LLC |
33,928,487 |
26.80 |
-4.36 |
| 2025-09-09 |
13D/A |
VOR / Vor Biopharma Inc. |
Reprogrammed Interchange LLC |
35,476,939 |
28.00 |
-3.82 |
| 2025-09-08 |
13D/A |
MLYS / Mineralys Therapeutics, Inc. |
Samsara BioCapital, L.P. |
6,346,194 |
8.20 |
10.63 |
| 2025-09-08 |
13D/A |
MLYS / Mineralys Therapeutics, Inc. |
Ra Capital Management, L.p. |
7,796,433 |
9.90 |
24.00 |
| 2025-09-05 |
13D/A |
TCRT / Alaunos Therapeutics, Inc. |
Pmgc Capital Llc |
0 |
0.00 |
-100.00 |
| 2025-09-05 |
13D/A |
VALN / Valneva SE - Depositary Receipt (Common Stock) |
Bpifrance Participations SA |
21,810,176 |
11.60 |
54.53 |
| 2025-09-05 |
13D/A |
INDV / Indivior PLC |
Two Seas Capital LP |
10,329,152 |
8.30 |
-11.43 |
| 2025-09-04 |
13D/A |
NBY / NovaBay Pharmaceuticals, Inc. |
Poplar Point Capital Management Llc |
1,020,300 |
17.52 |
0.00 |
| 2025-09-04 |
13D/A |
PRQR / ProQR Therapeutics N.V. |
Van Herk Investments B.v. |
13,274,690 |
12.60 |
8.79 |
| 2025-09-03 |
13D/A |
VTVT / vTv Therapeutics Inc. |
Samsara BioCapital, L.P. |
343,223 |
9.90 |
29.22 |
| 2025-09-02 |
13D |
STTK / Shattuck Labs, Inc. |
Orbimed Advisors Llc |
6,306,127 |
9.99 |
|
| 2025-09-02 |
13D/A |
CARM / Carisma Therapeutics, Inc. |
HealthCap VII, L.P. |
0 |
0.00 |
-100.00 |
| 2025-09-02 |
13D/A |
SNTI / Senti Biosciences, Inc. |
Celadon Partners SPV 24 |
13,404,441 |
45.00 |
37.10 |
| 2025-08-29 |
13D/A |
VOR / Vor Biopharma Inc. |
Reprogrammed Interchange LLC |
36,884,567 |
29.10 |
-5.36 |
| 2025-08-29 |
13D/A |
CARM / Carisma Therapeutics, Inc. |
HealthCap VII, L.P. |
2,014,372 |
4.80 |
-25.99 |
| 2025-08-28 |
13D/A |
ORMP / Oramed Pharmaceuticals Inc. |
Kidron Nadav |
3,116,729 |
7.60 |
32.97 |
| 2025-08-26 |
13D/A |
STOK / Stoke Therapeutics, Inc. |
Blue Horizon Enterprise Ltd |
2,256,181 |
4.10 |
-30.71 |
| 2025-08-26 |
13D/A |
STTK / Shattuck Labs, Inc. |
Redmile Group, LLC |
6,379,095 |
9.90 |
12.85 |
| 2025-08-26 |
13D/A |
IVVD / Invivyd, Inc. |
M28 Capital Management LP |
9,548,250 |
4.60 |
3.24 |
| 2025-08-26 |
13D |
NBY / NovaBay Pharmaceuticals, Inc. |
Lazar David E. |
1,200,048 |
19.99 |
|
| 2025-08-22 |
13D/A |
ARVN / Arvinas, Inc. |
Logos Global Management LP |
6,300,000 |
8.60 |
31.25 |
| 2025-08-22 |
13D |
HYEX / Healthy Extracts Inc. |
Swanson Donald William |
13,075,920 |
77.50 |
|
| 2025-08-22 |
13D/A |
ANIP / ANI Pharmaceuticals, Inc. |
Meridian Venture Partners II GP, L.P. |
1,034,570 |
4.80 |
-12.66 |
| 2025-08-21 |
13D/A |
CARM / Carisma Therapeutics, Inc. |
HealthCap VII, L.P. |
2,721,923 |
6.50 |
-19.90 |
| 2025-08-21 |
13D/A |
KROS / Keros Therapeutics, Inc. |
ADAR1 Capital Management, LLC |
5,389,264 |
13.27 |
-0.03 |
| 2025-08-20 |
13D/A |
NAMS / NewAmsterdam Pharma Company N.V. |
Frazier Life Sciences X, L.P. |
7,327,937 |
6.50 |
-55.36 |
| 2025-08-20 |
13D/A |
KALV / KalVista Pharmaceuticals, Inc. |
Frazier Life Sciences Public Fund, L.P. |
2,400,276 |
4.80 |
-50.89 |
| 2025-08-20 |
13D/A |
ARQT / Arcutis Biotherapeutics, Inc. |
Frazier Life Sciences VIII, L.P. |
8,943,712 |
7.50 |
0.92 |
| 2025-08-20 |
13D/A |
PHAT / Phathom Pharmaceuticals, Inc. |
Frazier Life Sciences Public Fund, L.P. |
5,985,327 |
8.60 |
-58.52 |
| 2025-08-20 |
13D/A |
MIRM / Mirum Pharmaceuticals, Inc. |
Frazier Life Sciences IX, L.P. |
3,735,220 |
7.60 |
-40.01 |
| 2025-08-20 |
13D/A |
PRQR / ProQR Therapeutics N.V. |
Van Herk Investments B.v. |
12,202,190 |
11.60 |
6.09 |
| 2025-08-19 |
13D/A |
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock) |
New Enterprise Associates 14, L.P. |
4 |
0.00 |
-100.00 |
| 2025-08-19 |
13D/A |
IOBT / IO Biotech, Inc. |
Novo Holdings A/S |
4,981,588 |
7.30 |
-14.46 |
| 2025-08-18 |
13D/A |
OSTX / OS Therapies Incorporated |
Auerbach Shalom |
2,677,570 |
8.50 |
-0.37 |
| 2025-08-18 |
13D/A |
CMPX / Compass Therapeutics, Inc. |
Commander Aggregator, LP |
7,788,150 |
4.50 |
|
| 2025-08-18 |
13D/A |
MRKR / Marker Therapeutics, Inc. |
New Enterprise Associates 16, L.P. |
1,625,678 |
12.60 |
0.00 |
| 2025-08-15 |
13D/A |
BHC / Bausch Health Companies Inc. |
Icahn Partners Master Fund LP |
0 |
0.00 |
-100.00 |
